The demand for antibacterial cleaning supplies continues to climb in response to the COVID-19 pandemic, and healthcare institutions are looking for effective alternatives to traditional solutions. To fill this need, Contec, Inc., the industry leader in critical cleaning products and cleanroom supplies, is scaling up production of its Sporicidin® brand disinfectant, most often used for mold and water damage remediation, and turned to diversified global manufacturer and materials science expert Milliken & Company to help produce mass quantities.
Since 1978, Sporicidin brand disinfectant products have been used for infection and contamination control by hospitals, medical and dental offices, veterinary clinics, and restoration professionals. The EPA-registered intermediate level disinfectant cleans, disinfects and deodorizes, and it provides 100% kill of pathogenic vegetative organisms, including MRSA, VRE and Avian Influenza A Virus (H9N2 and H1N1) with continuous residual activity for up to six months. Compatible with plastics, wood, glass and metals, alcohol-free Sporicidin brand disinfectant is non-staining, non-abrasive and non-corrosive. Notably, the disinfectant carries a Category IV EPA toxicity rating - the lowest toxicity rating given to antimicrobials.
“Milliken immediately came to mind when we decided to bring on a new manufacturing partner,” shared Jack McBride, Contec, Inc. CEO. “Milliken is a trusted, key community player with the mass production, quality systems and speed-to-market capabilities needed to help us provide critical cleaning solutions to healthcare facilities without delay.”
Sporicidin production at Milliken began on Tuesday, May 12, after a record ramp-up of only four weeks. Typical similar partnerships require three to six months to arrange.
“Companies are adapting their core competencies to meet the global challenges brought on by COVID-19,” said Halsey M. Cook, president and CEO of Milliken & Company. “Partnering with Contec, Inc. was a natural fit, and gave Milliken the opportunity to quickly reconfigure our manufacturing capabilities and rapidly solve problems for our customers and communities.”
Milliken quickly undertook an intensive technical process to manufacture Sporicidin brand disinfectant on behalf of Contec, Inc. Enabled by its research, development and manufacturing expertise, Milliken completed all EPA requirements and implemented training and protocols to safely produce a quality disinfectant.
Sporicidin brand disinfectant is available in ready-to-use 32 oz (0.65L) spray bottles, 1-gallon (3.8L) containers and pre-saturated wipes.
To purchase Sporicidin, please visit: https://www.aramsco.com/
May 20, 2020
Topic Area: Press Release
Recent Posts
Contaminants Under Foot: A Closer Look at Patient Room Floors
So-called dust bunnies on hospital room floors contain dust particles that turn out to be the major source of the bacteria humans breathe.
Power Outages Largely Driven by Extreme Weather Events
Almost half of power outages in the United States were caused by extreme weather events.
Code Compliance Isn't Enough for Healthcare Resilience
Intensifying climate risks are pushing hospitals to think beyond code requirements and toward long-term resilience.
Ribbon Cutting Marks First Phase Completion for New Montefiore Einstein Facility
The second phase is expected to be completed in the second half of 2027.
Nemours Children's Health Opens New Moseley Foundation Institute Hospital